Porphyrias are a group of rare genetic diseases. They affect how the body makes heme, a crucial part of red blood cells. This can cause problems with red blood cells, the nervous system, and the skin.
Every report comes from a Lived member, sent anonymously.
Have you tried Hemin for Porphyrias?
Porphyrias are a group of rare disorders in which the body has trouble making heme, the iron-containing part of hemoglobin that gives blood its red color. Heme is built in a series of steps, each handled by a different enzyme. When one enzyme does not work well, the chemicals made along the way, called porphyrins and their precursors, build up in the liver or bone marrow and cause illness. The porphyrias fall into two broad groups. Acute porphyrias, the most common being acute intermittent porphyria, affect the nervous system and cause attacks of severe pain, usually in the abdomen, along with nausea, vomiting, constipation, a fast heartbeat, anxiety or confusion, and sometimes muscle weakness. Attacks build over hours or days and can last days or weeks. Cutaneous porphyrias affect the skin. In porphyria cutanea tarda, the most common porphyria overall, sun-exposed skin such as the backs of the hands blisters, tears easily and heals slowly. In erythropoietic protoporphyria, the most common type in children, light exposure causes burning, stinging pain and swelling, usually without blisters. Two acute types, variegate porphyria and hereditary coproporphyria, can affect both the nerves and the skin. Because the types behave so differently, knowing exactly which porphyria someone has shapes nearly every decision about testing, treatment and prevention.
Most porphyrias are inherited. Depending on the type, a person develops it after inheriting one altered gene from a parent or two, one from each parent. Inheritance is not the whole story, though. Many people who carry a gene variant for an acute porphyria never have an attack. In people who do carry one, attacks are usually set off by something that pushes the liver to make more heme. Known triggers include certain medicines (including some antibiotics, anesthetics, seizure medicines and hormonal birth control), fasting, crash diets or other sharp drops in carbohydrate intake, alcohol, especially binge drinking, smoking, infections and stress. Female hormones, particularly progesterone, matter too, which helps explain why attacks are more common in women and often begin between the ages of 15 and 45, sometimes following the menstrual cycle. Porphyria cutanea tarda is different: it is usually acquired rather than inherited, although a gene variant contributes in some people. It tends to appear after age 40 and is driven by factors that stress the liver, especially excess iron (sometimes from hemochromatosis), heavy drinking, smoking, hepatitis C or HIV infection, and estrogen from birth control pills or hormone therapy. Erythropoietic protoporphyria and the other bone-marrow types are inherited and usually show up in early childhood.
Porphyria is often missed for years because its symptoms resemble many common problems. For acute porphyria, the abdominal pain is typically severe even though the belly is not tender to the touch and scans look normal. Specialists recommend considering it in anyone, especially women aged 15 to 50, who has repeated unexplained severe abdominal pain after a usual workup. The key first test for acute porphyria is a random urine sample measuring porphobilinogen (PBG) and delta-aminolevulinic acid (ALA), two of the heme-building precursors. During an attack these are usually markedly raised. A clearly raised result is treated as an acute porphyria until proven otherwise, so treatment does not wait for the type to be confirmed. Cutaneous porphyrias are diagnosed by measuring porphyrins in blood, urine or stool, and the pattern of which porphyrins are raised points to the specific type. Genetic testing then confirms the diagnosis and identifies the exact gene change. That result matters for relatives too, since family members can be tested for the same variant and, if they carry it, learn to avoid triggers before ever having symptoms. Genetic counseling can help families decide who to test and what the results mean.
Treatment depends entirely on the type of porphyria. A serious acute attack is treated in hospital. The main treatment is hemin (Panhematin), a form of heme given by vein once a day for several days. It limits the liver's overproduction of the chemicals that cause the attack, and symptoms often improve within 3 or 4 days. Glucose, by mouth or by vein, is also part of treatment. Care also includes strong pain relief, anti-nausea medicine, stopping any medicine that may have triggered the attack, and correcting problems such as high blood pressure and low sodium. Speed matters: hemin can stop an attack from progressing, but it cannot undo nerve damage that has already occurred. For people with frequent attacks, generally four or more a year, prevention is an option. Givosiran (Givlaari) is a monthly injection given by a clinician that lowers the liver's production of the attack-causing chemicals. In its main trial, adults taking it had about 70% fewer serious attacks than those on placebo. It requires regular blood tests, because it can affect liver and kidney function. Scheduled hemin infusions are another preventive approach. Liver transplantation can cure acute porphyria but is reserved for the rare person whose attacks remain severe despite everything else. Porphyria cutanea tarda usually responds well. The standard treatment lowers the body's iron by removing blood (phlebotomy), typically about a pint every two weeks until iron levels fall. Low-dose hydroxychloroquine, a long-established anti-malaria medicine, is an alternative for some people. Stopping alcohol, quitting smoking, treating hepatitis C and reviewing estrogen use all help keep it from coming back. For erythropoietic protoporphyria, careful protection from sunlight is the foundation. Adults may be offered afamelanotide (Scenesse), a small implant placed under the skin every two months that darkens skin pigment and lets people spend more time in light without pain; light protection is still needed alongside it. A few children with severe congenital erythropoietic porphyria may be offered a bone marrow transplant. People who avoid sunlight may need vitamin D supplements.
The course varies widely by type. Most people with acute porphyria have only one or a few attacks in their lifetime, and a small minority have frequent attacks. Between attacks, many people feel well, though some live with ongoing pain, fatigue or nerve symptoms. Day-to-day prevention is practical: eating regular meals with enough carbohydrate and avoiding fasting or rapid weight-loss diets, limiting alcohol, not smoking, and checking every new prescription, over-the-counter medicine and supplement for porphyria safety before taking it. Acute porphyria also carries long-term risks, including high blood pressure, chronic kidney disease and liver cancer, even in people with few symptoms. Specialists recommend yearly checks of kidney and liver function and, from age 50, a liver ultrasound every six months to catch liver cancer early. Porphyria cutanea tarda usually goes into remission with treatment, meaning skin stops blistering in sunlight and porphyrin levels return to normal, although old scars and skin color changes may remain. Ongoing liver monitoring is still recommended because it raises the risk of cirrhosis and liver cancer. Erythropoietic protoporphyria is lifelong and can shape choices about work, school and time outdoors; liver tests are followed over time because a small share of people develop gallstones or liver damage.
See a clinician if you have repeated episodes of severe abdominal pain that tests have not explained, or if sun-exposed skin blisters, scars or burns painfully after light exposure. If a relative has been diagnosed, ask whether you should be tested too. If you have a known porphyria, contact your care team promptly when you notice early signs of an attack such as building abdominal or back pain, nausea or dark reddish urine, and before starting any new medicine or diet. Go to the emergency department, and tell staff you have porphyria, for severe pain during a suspected attack or for muscle weakness, breathing difficulty, seizures or confusion. Attacks can become life-threatening without early hospital treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Porphyrias is like, what's helped you, or ask the community a question.